A detailed history of Deka Bank Deutsche Girozentrale transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 73,765 shares of BCRX stock, worth $552,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,765
Previous 73,765 -0.0%
Holding current value
$552,499
Previous $448,000 24.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

BUY
$11.56 - $19.76 $77,452 - $132,392
6,700 Added 9.99%
73,765 $1.21 Million
Q4 2021

Feb 02, 2022

BUY
$11.18 - $15.46 $20,124 - $27,828
1,800 Added 2.76%
67,065 $894,000
Q1 2021

Apr 28, 2021

SELL
$7.37 - $13.61 $294,800 - $544,400
-40,000 Reduced 38.0%
65,265 $643,000
Q4 2020

Mar 12, 2021

SELL
$3.37 - $8.61 $252,750 - $645,750
-75,000 Reduced 41.61%
105,265 $734,000
Q3 2020

Oct 29, 2020

BUY
$3.43 - $5.53 $618,308 - $996,865
180,265 New
180,265 $711,000
Q4 2019

Feb 04, 2020

SELL
$1.59 - $3.45 $50,085 - $108,675
-31,500 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$2.5 - $3.73 $78,750 - $117,495
-31,500 Reduced 50.0%
31,500 $100,000
Q2 2019

Aug 01, 2019

BUY
$2.91 - $9.15 $71,295 - $224,175
24,500 Added 63.64%
63,000 $229,000
Q1 2019

May 10, 2019

BUY
$7.38 - $9.72 $51,660 - $68,040
7,000 Added 22.22%
38,500 $276,000
Q4 2018

Feb 12, 2019

SELL
$6.51 - $9.6 $45,570 - $67,200
-7,000 Reduced 18.18%
31,500 $251,000
Q3 2018

Nov 09, 2018

SELL
$5.52 - $7.99 $5,520 - $7,990
-1,000 Reduced 2.53%
38,500 $0
Q1 2018

May 03, 2018

BUY
$4.35 - $5.82 $171,825 - $229,890
39,500 New
39,500 $189,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.